Compare MRDN & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRDN | BTMD |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | 1200 | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.7M | 71.0M |
| IPO Year | N/A | 2021 |
| Metric | MRDN | BTMD |
|---|---|---|
| Price | $13.83 | $2.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 39.0K | ★ 210.7K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | $16.30 | $2.03 |
| Revenue Next Year | $12.32 | $6.58 |
| P/E Ratio | ★ N/A | $40.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.01 | $1.27 |
| 52 Week High | $16.09 | $4.75 |
| Indicator | MRDN | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.72 | 65.62 |
| Support Level | $9.72 | $2.37 |
| Resistance Level | $16.09 | $2.79 |
| Average True Range (ATR) | 1.06 | 0.15 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 97.63 | 94.24 |
Meridian Holdings Inc is engaged in the online gaming and betting business, providing sports betting, online casino, and gaming operations across multiple jurisdictions in Europe, Africa, and Central and South America. The company has three reportable segments: MeridianBet Group, GMAG, and RKings & CFAC. The MeridianBet Group segment includes retail and online sports betting, casinos, and related gaming operations. The GMAG segment focuses on the resale of third-party gaming content, mainly serving customers in the Asia-Pacific region. The RKings & CFAC segment is involved in pay-to-enter prize competitions and trade promotions conducted in the United Kingdom and Australia. It generates the majority of its revenue from the MeridianBet Group segment.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.